News

Valve legend says he would "definitely" turn down working on Half-Life 3
Marc Laidlaw says that if Valve ever came asking for help on the elusive Half-Life 3, he'd reject it because fans deserve "new stuff." ...
It’s Official—Michael Bay Will Direct The ‘Skibidi Toilet’ Movie
Skibidi Toilet’ has conquered YouTube. Now the franchise is set to be a blockbuster directed by Michael Bay, whose ...
Agence France-Presse1h
Resolve Therapeutics and Duke Medical School Initiate Observational Study of Cell-free RNA in Polytrauma Patients
Resolve Therapeutics, a leader in the emerging field of cell-free nucleic acid therapeutics, today announced a collaboration with the Department of Surgery, Duke University School of Medicine to ...
From the boardroom to the basketball court
Other high-achievers come to mind as natural role models, too. Take four-time Paralympian Matt Stutzman, who competed in the ...
Half-Life 3 is reportedly playable in its entirety and could be announced this year
In March, Valve concept artist Evgeniy Evstratiy claimed that he was in ... Before you get your hopes up, remember that Half-Life 2 recently celebrated its 20-year anniversary, and we still don’t have ...
University of Dundee8d
Trial results could herald “major step forward” in battle against hard-to-treat lung infections
Experts at the University of Dundee have announced promising results from a clinical trial of a potential new antibody ...
GEN - Genetic Engineering and Biotechnology News8d
Scratch That? De Novo Antibody Design Enters the AI Drug Discovery Toolbox
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
Reskilling for AI: What employees should start learning from today?
As AI reshapes industries, reskilling has become more than a buzzword. With the rise of tools like ChatGPT and Gemini, ...
The Manila Times16d
Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Strengthened Balance Sheet - On March 18, 2025, the Company completed a public equity financing for gross proceeds of approximately $201.2 million, before deducting fees and expenses. The Company ...